Free Trial

Cardinal Health Q2 2025 Earnings Report

Cardinal Health logo
$128.32 +0.56 (+0.43%)
As of 03:59 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

Cardinal Health EPS Results

Actual EPS
$1.93
Consensus EPS
$1.74
Beat/Miss
Beat by +$0.19
One Year Ago EPS
N/A

Cardinal Health Revenue Results

Actual Revenue
N/A
Expected Revenue
$53.90 billion
Beat/Miss
N/A
YoY Revenue Growth
N/A

Cardinal Health Announcement Details

Quarter
Q2 2025
Time
Before Market Opens

Cardinal Health Earnings Headlines

Cardinal Health, Inc. (CAH) Q2 2025 Earnings Call Transcript
Why Buffett, Griffin and 100 members of Congress are Piling into this One Investment
This isn't just another investment. It might be the last retirement stock you'll ever need. But this window of opportunity is closing fast.
Cardinal Health raises FY25 EPS view to $7.85-$8.00 from $7.75-$7.90
Cardinal Health Inc Q2 Profit Increases, Beats Estimates
See More Cardinal Health Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Cardinal Health? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Cardinal Health and other key companies, straight to your email.

About Cardinal Health

Cardinal Health (NYSE:CAH) operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home. The company operates in two segments, Pharmaceutical and Medical. The Pharmaceutical segment distributes branded and generic pharmaceutical, specialty pharmaceutical, and over-the-counter healthcare and consumer products. The segment also provides services to pharmaceutical manufacturers and healthcare providers for specialty pharmaceutical products; operates nuclear pharmacies and radiopharmaceutical manufacturing facilities; repackages generic pharmaceuticals and over-the-counter healthcare products; and provides pharmacy management services to hospitals. The Medical segment manufactures, sources, and distributes Cardinal Health branded medical, surgical, and laboratory products and devices that include exam and surgical gloves; needles, syringe, and sharps disposals; compressions; incontinences; nutritional delivery products; wound care products; single-use surgical drapes, gowns, and apparels; fluid suction and collection systems; urology products; operating room supply products; and electrode product lines. The segment also distributes a range of national brand products, including medical, surgical, and laboratory products; provides supply chain services and solutions to hospitals, ambulatory surgery centers, clinical laboratories, and other healthcare providers; and assembles and sells sterile, and non-sterile procedure kits. The company was incorporated in 1979 and is headquartered in Dublin, Ohio.

View Cardinal Health Profile

More Earnings Resources from MarketBeat